SYSTEMIC LUPUS ERTHEMATOSUS (SLE)
Clinical trials for SYSTEMIC LUPUS ERTHEMATOSUS (SLE) explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERTHEMATOSUS (SLE) trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERTHEMATOSUS (SLE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on lupus in early trial
Disease control Not yet recruitingThis early-stage study tests a new treatment called KN5501 for people with moderate to severe lupus that hasn't responded to standard therapies. The treatment uses specially designed immune cells (CAR-NK cells) to target and reduce harmful B cells that drive the disease. The main…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS (SLE)
Phase: PHASE1 • Sponsor: Ruitherapeutics Co., LTD • Aim: Disease control
Last updated May 26, 2026 08:57 UTC
-
Lupus study targets hidden immune drivers of high blood pressure
Knowledge-focused Not yet recruitingThis study tests whether a supplement called 2-HOBA can lower blood pressure and reduce immune system overactivity in people with lupus. About 42 adults with stable lupus and mild high blood pressure will receive either 2-HOBA or a placebo for 4 weeks, then switch after a break. …
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS (SLE)
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC